Advanced Solid Cancers

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor

Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patients

Exploratory Clinical Study of Targeted Activated DC and CAR-T Therapy in Advanced Solid Cancers

Exploratory Clinical Study on Memory NK Cell Therapy for Advanced Metastatic Solid Tumors

A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors

Study of SC-102 in Patients With Advanced Solid Tumors

AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy

An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers

A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors

Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers

Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers

A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer

Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain